| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |